Special Issue "Gynecologic Oncology: From Molecular Mechanisms to Targeted Therapies 2.0"
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (31 May 2021).
Interests: ovarian cancer; tumour microenvironment; extracellular matrix; metastasis
Interests: immunotherapy of ovarian cancer, medical applications of plasma
Interests: Gynaecological Oncology
This Special Issue calls for a joint collaborative effort to illustrate how the understanding of the molecular mechanisms of gynecological cancers may lead to potential targeted therapies.
Considerable progress has been made in deciphering the molecular mechanisms for gynecologic cancers in the past decade. Integrated genomic analyses of large cohorts of ovarian cancer and uterine cancer, through The Cancer Genome Atlas (TCGA) effort, have generated a large amount of data regarding early mutation events and dysregulated pathways in carcinogenesis. Various clinical trials, based on specific molecular features, are being developed or in early phase clinical studies. Targeting cancer metabolism, tumor microenvironment, and immunotherapy are also in the horizon.
We encourage and invite researchers with related experiences in ovarian cancer, uterine cancer, cervical cancer, or other rare gynecological cancers to contribute original research articles or review articles.
Dr. Hiroaki Kajiyama
Dr. Carmela Ricciardelli
Prof. Martin Oehler
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- ovarian cancer
- uterine cancer
- cervical cancer
- tyrosine kinases
- growth factor receptors
- DNA repair
- cell cycle
- cancer metabolism
- resistance to targeted therapies